Cost-effective microbiome-based corn hybrid performance predictor
A digital twin approach uses early corn microbiome analysis to predict yield-related traits such as nutrient efficiency and disease resistance. The method combines DNA sequencing with a custom analysis pipeline to process data efficiently, offering a scalable alternative to traditional, labor-intensive plant trait screening. The technology has been applied to predict hybrid phenotypes across multiple crops and is at TRL 5.
Overview
A digital twin approach optimizes corn hybrid performance by leveraging early microbiome analysis. The solution predicts key agricultural traits, including nutrient use efficiency, disease resistance, and abiotic stress tolerance, which are important for maximizing yield. By using a cost-effective combination of DNA sequencing and a custom analysis pipeline, the method provides a scalable alternative to traditional, labor-intensive plant trait screening processes.
Technical specifications
Key features:
- Utilizes early corn microbiome analysis to predict yield-related traits
- Combines DNA sequencing with a custom analysis pipeline for efficient data processing
- Proven diagnostic tool for predicting hybrid phenotypes across various crops, including damping-off tolerance in sugar beet and ralstonia resistance in tomatoes and eggplants
- Collaborative model involving DNA sequencing and data processing by the solution provider, with data and root samples provided by external partners
Technology readiness level
Currently, this technology is at TRL 5, having been successfully applied to predict hybrid phenotypes in multiple crops. An ongoing validation effort is planned to further assess the model’s ability to predict yield in corn hybrids, with a workplan designed to refine and benchmark the prediction model over a 6-month period.
About Cybiome GmbH
Cybiome GmbH is a life sciences company focused on engineering and optimizing natural microbial communities to address challenges in health, nutrition, and environmental sustainability. The company operates a discovery platform that integrates data sciences, mathematical modeling, and artificial intelligence to design microbiome-based solutions. Their core capabilities include high-throughput DNA sequencing, bioinformatics analysis, and the development of predictive algorithms for drug design and diagnostic reporting. By partnering with academic institutions, Cybiome provides comprehensive services ranging from soil health analysis and microbiome diagnostic reports to the design of novel formulations aimed at enhancing microbiome functionality.
These solutions are designed to support R&D initiatives for partners in sectors such as agriculture and biopharmaceuticals. By providing turnkey solutions for microbiome diagnostics and improvement, the company assists clients in accelerating innovation, supporting decision-making, and developing sustainable alternatives to traditional agricultural inputs like pesticides and fertilizers. Cybiome also participates in collaborative research, such as the Cousin project, where it contributes expertise in microbiome data processing and the identification of biomarkers to drive improvements in plant traits.
delivered to your inbox.